Burkitt lymphoma in a child with atopic dermatitis and a 7-year history of regular topical tacrolimus use.

Abstract

We describe the case of a boy who presented with abdominal Burkitt lymphoma; he had been regularly using tacrolimus ointment 0.1% for severe recurrent atopic dermatitis for 7 years immediately prior to developing cancer.

We present his medical history and review the current knowledge regarding a link between topical tacrolimus and malignancy risk.

Full Text

Subjects

Similar articles

Alcohol-induced rash caused by topical tacrolimus. (2005-10-04)
Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis. (2006-12-25)
Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. (2004-04-20)
Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. (2005-10-03)
Treatment of atopic eyelid disease using topical tacrolimus following corticosteroid discontinuation in a patient with open-angle glaucoma. (2004-10-25)
[Place of immunosuppressors in atopic dermatitis]. (2013-03-11)
Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis. (2003-09-04)
Ethanol-induced flushing with topical pimecrolimus use. (2008-04-16)
Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations. (2013-04-03)

Authors

Publication date

2012-04-25

Journal

Cutis; cutaneous medicine for the practitioner
Cutis (0011-4162)

Journal topics

Language

Eng.

Copyright

Cutis; cutaneous medicine for the practitioner

University of Kentucky College of Medicine, Lexington, KY 40536-0096, USA.

Release reference

Cutis. 2012 Mar;89(3):117-20

Related books

Español | English

© Galenicom 1999-2013